ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $163.94bn
- $191.33bn
- $44.33bn
Barclays lifts Abbott PT on Exact Sciences acquisition
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
Brief: Abbott Completes Acquisition Of Exact Sciences
-Altai Capital presses OraSure to sell and give it board seats, letter says (updated)
Abbott set to face trial over claims premature infant formula caused deadly disease
Newscasts - Inside the Mexico villa where El Mencho spent his final hours
Brief: Abbott Seeks $20 Billion In Us Bond Sale For Exact Sciences Deal - Bloomberg News
Brief: Abbott Files For Eight-Part Notes Offering, Size Not Disclosed - SEC Filing
Brief: Exact Sciences Stockholders Approve Acquisition By Abbott
Brief: Abbott Declares Quarterly Dividend Of 63 Cents Per Share
Medtronic beats quarterly estimates on robust demand for heart devices (updated)
Medtronic beats quarterly profit estimates on robust demand for heart devices
US FDA classifies Abbott's glucose sensor recall as most serious after seven deaths (updated)
Abbott recalls glucose sensors after seven deaths linked to faulty readings
Brief: FDA Says Abott Diabetes Care Removes Some Freestyle Libre 3 And Freestyle Libre 3 Plus Sensors
Brief: German Cartel Office Approved Planned Acquisition Of Exact Sciences By Abbott
Stryker raises annual profit forecast on strong sales for medical devices
Abbott faces India scrutiny in cough syrup abuse investigation, documents show
Street View: Brokerages see Abbott's growth picking up later in 2026